Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD

NCT05321485 is registered in ClinicalTrials.gov with Maxima Medical Center as lead sponsor.

NCT NCT05321485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05321485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD
Lead sponsor
Maxima Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
March 16, 2022
Completion date
September 16, 2022
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, inflammatory bowel diseases, ulcerative colitis